About this trial
This study will compare different doses of a green fluorescent product that is administered during weight loss surgery in order to observe where blood vessels are located. There is uncertainty around the optimal dose of this product for patients with obesity, so this study will aim to study if the dose in the minimal range recommended by international guidelines is sufficient for most patients or if higher doses are needed with increasing body mass index.
Eligibility criteria
Qualifiers
Diagnosis of obesity with a BMI ≥ 30 kg/m²
Scheduled for revisional bariatric surgery
Disqualifiers
Allergy to iodides.
Anticoagulation with products containing sodium bisulfite (due to the risk of ICG-FA inactivation).
Use of radioactive iodine studies within the past 7 days.
Pregnant, breastfeeding, or planning to become pregnant within the next year (due to unknown teratogenic or fertility effects of ICG-FA).
Trial design
Treatments tested in this trial
- Indocyanine Green Angiogram
Treatment groups
Sponsors and collaborators
Instituto Mexicano del Seguro Social
Lead sponsor
Bariatric Medical Center
Collaborator